Quest Partners LLC Raises Stake in Colgate-Palmolive (NYSE:CL)

Quest Partners LLC increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 69.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,829 shares of the company's stock after purchasing an additional 13,066 shares during the quarter. Quest Partners LLC's holdings in Colgate-Palmolive were worth $3,304,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive in the 2nd quarter valued at about $25,000. Continuum Advisory LLC grew its holdings in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth $53,000. Finally, Gradient Investments LLC boosted its position in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CL shares. Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. HSBC reaffirmed a "hold" rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Finally, TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Stock Up 1.2 %

Shares of Colgate-Palmolive stock traded up $1.09 during trading hours on Monday, hitting $94.65. The company had a trading volume of 4,487,695 shares, compared to its average volume of 4,388,260. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a twelve month low of $75.17 and a twelve month high of $109.30. The company has a market cap of $77.33 billion, a P/E ratio of 27.12, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company's 50-day moving average is $99.06 and its two-hundred day moving average is $98.55.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insider Activity

In other news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.